Greetings, and welcome to the Know Labs First Quarter 2025 Earnings Conference Call. Please note, this conference call is being recorded. I will now turn the conference over to Ron Erickson, Know Labs ...
Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million - Following pre-NDA meeting with FDA, on track to submit TransCon CNP ...